Search

Your search keyword '"Matej Orešič"' showing total 434 results

Search Constraints

Start Over You searched for: Author "Matej Orešič" Remove constraint Author: "Matej Orešič"
434 results on '"Matej Orešič"'

Search Results

151. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe

152. An Overview of Metabolomics Data Analysis: Current Tools and Future Perspectives

153. Serum, plasma and erythrocyte membrane lipidomes in infants fed formula supplemented with bovine milk fat globule membranes

154. The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity

155. Self-organization and missing values in SOM and GTM

156. Serum lipid and serum metabolite components in relation to anthropometric parameters in EPIC-Potsdam participants

157. PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium

158. Use of Blood Biomarkers in the Assessment of Sports-Related Concussion-A Systematic Review in the Context of Their Biological Significance

159. Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort

160. Targeted Serum Metabolite Profiling Identifies Metabolic Signatures in Patients with Alzheimer's Disease, Normal Pressure Hydrocephalus and Brain Tumor

161. Hypothalamic AMPK-ER Stress-JNK1 axis mediates the central actions of thyroid hormones on energy balance

162. High-Dose Simvastatin Exhibits Enhanced Lipid-Lowering Effects Relative to Simvastatin/Ezetimibe Combination Therapy

163. Phenolic metabolites as compliance biomarker for polyphenol intake in a randomized controlled human intervention

164. Characterising metabolically healthy obesity in weight-discordant monozygotic twins

165. Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patients

166. Adaptive Changes of the Insig1/SREBP1/SCD1 Set Point Help Adipose Tissue to Cope With Increased Storage Demands of Obesity

167. Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol

168. Decreased Cord-Blood Phospholipids in Young Age-at-Onset Type 1 Diabetes

169. Comparative effectiveness of decompressive craniectomy versus craniotomy for traumatic acute subdural hematoma (CENTER-TBI): an observational cohort studyResearch in context

170. Lipidomics in biomedical research-practical considerations

171. The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans

172. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men

173. Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites

174. Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses

175. Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

176. Metabolic transformations of dietary polyphenols: comparison between in vitro colonic and hepatic models and in vivo urinary metabolites

177. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction

178. Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model

179. Peroxisome Proliferator-Activated Receptor γ-Dependent Regulation of Lipolytic Nodes and Metabolic Flexibility

180. 15-hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition and promotes cell migration in cultured breast cancer cells

181. Metabolomics in the Studies of Islet Autoimmunity and Type 1 Diabetes

182. Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins

183. Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer—Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling

184. Deletion of the metabolic transcriptional coactivator PGC1β induces cardiac arrhythmia

185. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy

186. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression

187. Drug metabolome of the Simvastatin formed by human intestinal microbiota in vitro

188. Data Analysis Tool for Comprehensive Two-Dimensional Gas Chromatography/Time-of-Flight Mass Spectrometry

189. Matching samples of multiple views

190. Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity

191. Multivariate multi-way analysis of multi-source data

192. Dietary carbohydrate modification alters serum metabolic profiles in individuals with the metabolic syndrome

193. 42.3 METABOLOMICS APPROACHES TO STUDY METABOLIC CO-MORBIDITIES IN PSYCHOTIC DISORDERS

194. Saturated fat is more metabolically harmful for the human liver than polyunsaturated fat or simple sugars

195. 42. METABOLISM AND CO-MORBIDITIES IN PSYCHOTIC DISORDERS

196. Metabolomics in Angiotensin II-Induced Cardiac Hypertrophy

197. The gut microbiota modulates host energy and lipid metabolism in mice

198. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance

199. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum

200. Functional prediction of unidentified lipids using supervised classifiers

Catalog

Books, media, physical & digital resources